1-3 of 3
Jost von Hardenberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective Feasibility Study of Single-Shot Antibiotic Prophylaxis in Transrectal Focal Ablation of Prostate Cancer

Available to Purchase
Subject Area:
Further Areas
Niklas Westhoff, Manuel Ritter, Máté Maros, Marie-Claire Rassweiler-Seyfried, Maurice-Stephan Michel, Patrick Honeck, Jost von Hardenberg
Journal: Urologia Internationalis
Urol Int (2020) 104 (5-6): 378–385.
https://doi.org/10.1159/000507123
Published Online: 12 May 2020
View article titled, Prospective Feasibility Study of Single-Shot Antibiotic Prophylaxis in Transrectal Focal Ablation of Prostate Cancer
Open the PDF for Prospective Feasibility Study of Single-Shot Antibiotic Prophylaxis in Transrectal Focal Ablation of Prostate Cancer in another window
Journal Articles

Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review

Available to Purchase
Subject Area:
Further Areas
Jost von Hardenberg, Maike Schwartz, Thorsten Werner, Stefan Fuxius, Arne Strauss, Thomas Stefan Worst, Philipp Nuhn, Christian Bolenz, Elmar Heinrich
Journal: Urologia Internationalis
Urol Int (2017) 99 (4): 414–421.
https://doi.org/10.1159/000477943
Published Online: 13 July 2017
View article titled, Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review
Open the PDF for Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review in another window
Journal Articles

Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Urothelial Carcinoma Following Third-Line Treatment with Trastuzumab and Gemcitabine

Available to Purchase
Subject Area:
Further Areas
Felix Wezel, Philipp Erben, Timo Gaiser, Johannes Budjan, Jost von Hardenberg, Maurice Stephan Michel, Christian Bolenz
Journal: Urologia Internationalis
Urol Int (2018) 100 (1): 122–125.
https://doi.org/10.1159/000443280
Published Online: 19 January 2016
View article titled, Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Urothelial Carcinoma Following Third-Line Treatment with Trastuzumab and Gemcitabine
Open the PDF for Complete and Durable Remission of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Urothelial Carcinoma Following Third-Line Treatment with Trastuzumab and Gemcitabine in another window